Transcatheter Mitral Valve Replacement With a New Supra-Annular Valve: First-in-Human Experience With the AltaValve System

Alfredo Nunes Ferreira-Neto,François Dagenais,Mathieu Bernier,Eric Dumont,Afonso B. Freitas‐Ferraz,Josep Rodes–Cabau

Transcatheter Mitral Valve Replacement With a New Supra-Annular Valve: First-in-Human Experience With the AltaValve System

2019

Alfredo Nunes Ferreira-Neto
François Dagenais
Mathieu Bernier
Eric Dumont
Afonso B. Freitas‐Ferraz
Josep Rodes–Cabau

Transcatheter mitral valve replacement (TMVR) systems may interact with the subvalvular apparatus, associate with an increased risk for left ventricular outflow tract obstruction, and are limited by mitral annular dimension and calcification [(1)][1]. The AltaValve (4C Medical Technologies,

Keywords:

Internal medicine
Mitral valve replacement
Calcification
Cardiology
Medicine
Ventricular outflow tract obstruction
mitral regurgitation
first in human
increased risk

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations